Pasireotide is a somatostatin analog classified as a peptide receptor agonist used primarily in the treatment of Cushing’s disease, where it acts by binding to somatostatin receptors to inhibit hormone… Read more
Pasireotide is a somatostatin analog classified as a peptide receptor agonist used primarily in the treatment of Cushing’s disease, where it acts by binding to somatostatin receptors to inhibit hormone secretion. To support the rigorous demands of pharmaceutical analysis, this category provides a range of reference materials, including the active pharmaceutical ingredient and its associated salt forms. Analytical laboratories utilize these compounds for comprehensive impurity profiling and to facilitate precise quality control testing throughout the drug development lifecycle. The inclusion of stable isotope labelled compounds, such as deuterium-labelled variants, enables accurate quantification and method validation in mass spectrometry-based studies. These high-quality reference standards and impurities are essential tools for ensuring the safety, efficacy, and purity of drug products during both research and regulatory compliance processes.